Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1QZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,419
Award facts
- Contract value 100% obligated
- $31,418.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,418.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 mg/24 mL vials on December 1, 2025, with an ultimate completion date of December 22, 2025. This non-set-aside award will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications and medical commodities to military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that consistently wins competitive federal contracts with the Defense Logistics Agency to supply brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements for military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for OPDIVO—an oncology therapeutic—exemplifies the company's role as a critical vendor supporting the federal medical supply chain with firm fixed-price transactions ranging from modest to substantial order values.
Quick answers
Who was awarded contract SPE2DR26FG1QZ?
SPE2DR26FG1QZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FG1QZ worth?
The government has obligated $31,419 on SPE2DR26FG1QZ.
Is contract SPE2DR26FG1QZ an order under another contract?
Yes. SPE2DR26FG1QZ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1QZ competed?
The extent of competition for SPE2DR26FG1QZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award